Valeant to bid for Botox maker Allergan
Valeant to bid for Botox maker Allergan; Activist investor Ackman discloses $4.1B stake
Associated Press
2014-04-22 06:22 AM

NEW YORK (AP) -- Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman to make a bid for Botox maker Allergan.

Valeant said Monday that it intends to propose a merger with Allergan using a combination of Valeant stock and cash. The transaction size has not been disclosed, but Valeant expects the cash portion of the deal to be at least $15 billion.

In a separate filing, Ackman's Pershing Square Capital Management said it owns a 9.7 percent stake in Allergan worth $4.1 billion. Ackman's stake would make a Allergan deal worth around $40 billion.

Allergan's star product is Botox, the anti-wrinkle treatment. The company sold $2 billion in Botox last year, up roughly 12 percent from the prior year.

Allergan's stock jumped $28, or 20 percent, to $170 in after-hours trading.

Advertisement »
HOME |  WORLD |  Politics |  Business |  Sports |  TAIWAN |  Technology |  Health |  Society |  OPINION |  E-Paper
  • Taiwan News  ©  2016 All Rights Reserved.